Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MFN1 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | BBC3 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | TAGLN | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
mRNA | CNKSR1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
mRNA | ASB3 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | MYL9 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | PAPSS2 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | PDGFRB | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | C5orf42 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | ITGB4 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |